Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Fluvoxamine“
Suchtreffer
Begriffe & Kennungen
Adasuve · 4.5 · 18 irregular manner. Concomitant use of CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin, enoxacin, proprano
Eintrag öffnenAdasuve · 4.5 · 6 irregular manner. Concomitant use of CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin, enoxacin, propranol
Eintrag öffnenAzilect · 4.5 · The concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.4).
Eintrag öffnenAzilect · 4.8 · Serotonin syndrome Rasagiline clinical trials did not allow concomitant use of fluoxetine or fluvoxamine with
Eintrag öffnenCerdelga · 4.5 · Caution should be used with weak CYP3A inhibitors (e.g., amlodipine, cilostazol, fluvoxamine, goldenseal, ison
Eintrag öffnenCibinqo · 4.5 · When 100 mg abrocitinib was administered concomitantly with fluvoxamine (a strong CYP2C19 and moderate CYP3A i
Eintrag öffnenCymbalta · 4.3 · Cymbalta should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent CYP1A2 inh
Eintrag öffnenDuloxetine Lilly · 4.3 · Duloxetine Lilly should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent CY
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.3 · Duloxetine Viatris should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent
Eintrag öffnenDuloxetine Zentiva · 4.3 · Duloxetine Zentiva should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent
Eintrag öffnenEsbriet · 4.5 · Esbriet is contraindicated in patients with concomitant use of fluvoxamine (see section 4.3). Fluvoxamine shou
Eintrag öffnenEsbriet · 4.5 · Fluvoxamine and inhibitors of CYP1A2
Eintrag öffnenEsbriet · 4.5 · In a Phase 1 study, the co-administration of Esbriet and fluvoxamine (a strong inhibitor of CYP1A2 with inhibi
Eintrag öffnenFluvoxamin
Eintrag öffnenFortacin · 4.5 · Medicinal products that inhibit cytochrome P450 (CYP) 1A2 reduce the clearance of lidocaine (e.g. fluvoxamine,
Eintrag öffnenKerendia · 4.5 · Weak CYP3A4 inhibitors The physiologically based pharmacokinetic (PBPK) simulations suggest that fluvoxamine (
Eintrag öffnenOlanzapine Glenmark Europe · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark Europe · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark Europe · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark Europe · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnen